Markets:

Overview

News

Currencies

International

Treasuries

Lyra Therapeutics, Inc. - Common Stock (NQ:LYRA)

3.540 +0.040 (+1.14%)

Streaming Delayed Price Updated: 11:48 AM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lyra Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗

September 08, 2022

Via Benzinga

Lyra Therapeutics: Q2 Earnings Insights ↗

August 09, 2022

Lyra Therapeutics (NASDAQ:LYRA) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 18, 2022

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.

Via Benzinga

Lyra Therapeutics's Return On Capital Employed Insights ↗

June 10, 2022

According to data from Benzinga Pro, during Q1, Lyra Therapeutics's (NASDAQ:LYRA) reported sales totaled $5.37 million. Despite a 48.51% increase in earnings, the company posted a loss of $7.01...

Via Benzinga

Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor ↗

May 25, 2022

Via Benzinga

Recap: Lyra Therapeutics Q1 Earnings ↗

May 10, 2022

Lyra Therapeutics (NASDAQ:LYRA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Lyra Therapeutics Stock Surges On Equity Raise Of $100M ↗

April 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗

May 24, 2022

Upgrades

Via Benzinga

7 Stocks to Watch for Major Insider Trading Clues ↗

April 27, 2022

These seven stocks show varying degrees of insider trading, which can provide a hint regarding each company or fund's performance.

Via InvestorPlace

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 10, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 20, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 20, 2022

Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...

Via Benzinga

Executives Buy More Than $32M Of 4 Stocks ↗

April 18, 2022

Although U.S. stock futures traded lower this morning on Monday, there were a few notable insider trades.

Via Benzinga

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗

April 17, 2022

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting...

Via Benzinga

51 Biggest Movers From Thursday ↗

April 18, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 14, 2022

Gainers

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2% ↗

April 08, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 08, 2022

Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

April 08, 2022

Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million. TSR, Inc. (NASDAQ...

Via Benzinga

Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide ↗

April 08, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday.

Via Benzinga

Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday ↗

April 08, 2022

We're diving into the top penny stocks for today in our market update for Friday with all the latest news that's moving shares!

Via InvestorPlace

Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗

April 08, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 04, 2022

Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...

Via Benzinga

Lyra Therapeutics Kickstarts LYR-210 Pivotal Program in Surgically Naïve Chronic Rhinosinusitis Patients ↗

January 24, 2022

Lyra Therapeutics Inc (NASDAQ: LYRA) has initiated its Phase 3 ENLIGHTEN I trial of LYR-210 in adult, surgically naïve chronic rhinosinusitis (CRS) patients....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 13, 2022

Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 01, 2021

Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares...

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.